Indeed, oral administration of ATE upregulated ISGs expression, pro-inflammatory cytokines, and IFN mRNA markedly in BALB/c mice, highlighting its potential to boost systemic immunity and protect against influenza. The gene discussed is IFNA1; the disease is influenza.